Bridge Therapeutics, Inc.
Amendment
CIK: 0001724287·Pharmaceuticals·DELAWARE·Filed: Apr 24, 2019
Total Offering
Indefinite
Amount Sold
$2,000,000
Investors
11
First Sale
Apr 8, 2019
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(c)
- Entity Type
- Corporation
- Year Incorporated
- 2016
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Kelley S Alton | Related Person |
| Joseph Mullin | Related Person |
| David H Bergstrom | Related Person |
| Diana Harshbarger | Related Person |
| James G Sullivan | Related Person |
| Elizabeth Kelley | Related Person |
| Tim Peara | Related Person |
| Russell Kelley | Related Person |
Company
SEC Filing
0001724287-19-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free